XenoPort Announces New Employment Inducement Awards – PharmaLive.com (press release)

by admin on February 6, 2013

XenoPort Announces New Employment Inducement Awards
PharmaLive.com (press release)
Horizant® (gabapentin enacarbil) Extended-Release Tablets is approved in the United States for the treatment of moderate-to-severe primary restless legs syndrome (RLS) in adults and for the management of postherpetic neuralgia in adults

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: